Jonathan Poole

2015 - Genocea Biosciences

In 2015, Jonathan Poole earned a total compensation of $1.1M as Chief Financial Officer at Genocea Biosciences, a 67% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$115,360
Option Awards$620,360
Salary$328,000
Other$7,295
Total$1,071,015

Poole received $620.4K in option awards, accounting for 58% of the total pay in 2015.

Poole also received $115.4K in non-equity incentive plan, $328K in salary and $7.3K in other compensation.

Rankings

In 2015, Jonathan Poole's compensation ranked 7,613th out of 13,638 executives tracked by ExecPay. In other words, Poole earned more than 44.2% of executives.

ClassificationRankingPercentile
All
7,613
out of 13,638
44th
Division
Manufacturing
2,887
out of 5,187
44th
Major group
Chemicals And Allied Products
1,047
out of 1,857
44th
Industry group
Drugs
844
out of 1,531
45th
Industry
Biological Products, Except Diagnostic Substances
145
out of 260
44th
Source: SEC filing on April 21, 2017.

Poole's colleagues

We found two more compensation records of executives who worked with Jonathan Poole at Genocea Biosciences in 2015.

2015

William Clark

Genocea Biosciences

Chief Executive Officer

2015

Seth Hetherington

Genocea Biosciences

Chief Medical Officer

News

In-depth

You may also like